Treating Nasal Congestion May Prevent Asthma Attacks
The use of intranasal corticosteroids to treat an upper airways condition (rhinitis, sinusitis, or otitis media) appears to lower the risk for emergency department (ED) visits for acute asthma exacerbations, according to findings published in the Journal of Allergy and Clinical Immunology. In fact, the number of ED visits was 30% lower among people with asthma who received intranasal corticosteroids, compared with those who were untreated. This rate reduction was found even after the researchers adjusted for age, sex, frequency of orally inhaled corti-costeroid and beta-agonist dispensing, amount and type of ambulatory care for asthma, and diagnosis of an upper airways condition. The risk reduction was even greater?50%?among patients with more than 3 intranasal corticosteroid prescriptions dispensed per year.
Articles in this issue
over 23 years ago
Article
Court Orders Mistrial After Plaintiff Participates in TV Report on Pharmacy ErrorsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025